{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:05:59Z","timestamp":1791227159013,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":3374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.3945\/an.112.002758","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T13:48:16Z","timestamp":1352900896000},"page":"755-762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Homocysteine Imbalance: a Pathological Metabolic Marker"],"prefix":"10.1016","volume":"3","author":[{"given":"Kevin L.","family":"Schalinske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Smazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/an.112.002758_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.nu.12.070192.001431","article-title":"Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease","volume":"12","author":"Kang","year":"1992","journal-title":"Annu Rev Nutr"},{"key":"10.3945\/an.112.002758_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.3945\/an.112.002758_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.nu.06.070186.002203","article-title":"Labile methyl groups and the promotion of cancer","volume":"6","author":"Newberne","year":"1986","journal-title":"Annu Rev Nutr"},{"key":"10.3945\/an.112.002758_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.nu.10.070190.001425","article-title":"The role of nutrition in neural tube defects","volume":"10","author":"Scott","year":"1990","journal-title":"Annu Rev Nutr"},{"key":"10.3945\/an.112.002758_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.71","article-title":"Homocysteine metabolism and its relation to health and disease","volume":"36","author":"Williams","year":"2010","journal-title":"Biofactors"},{"key":"10.3945\/an.112.002758_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/bjc.2011.550","article-title":"Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research","volume":"106","author":"Shenker","year":"2012","journal-title":"Br J Cancer"},{"key":"10.3945\/an.112.002758_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.nutr.22.010402.102932","article-title":"Genetic effects of methylation diets","volume":"22","author":"Van den Veyver","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"10.3945\/an.112.002758_bib8","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1016\/S0021-9258(19)45067-9","article-title":"Competing methyltransferase systems","volume":"247","author":"Kerr","year":"1972","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib9","series-title":"The biochemistry of S-adenosylmethionine and related compounds","first-page":"3","article-title":"S-adenosylamino acids thirty years later: 1951\u20131981","author":"Cantoni","year":"1982"},{"key":"10.3945\/an.112.002758_bib10","series-title":"Natural sulfur compounds","first-page":"67","article-title":"The role of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in the control of biological methylations","author":"Cantoni","year":"1980"},{"key":"10.3945\/an.112.002758_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0026-0495(75)90040-2","article-title":"Labile methyl balances for normal humans on various dietary regimens","volume":"24","author":"Mudd","year":"1975","journal-title":"Metabolism"},{"key":"10.3945\/an.112.002758_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0026-0495(80)90192-4","article-title":"Labile methyl group balances in the human: the role of sarcosine","volume":"29","author":"Mudd","year":"1980","journal-title":"Metabolism"},{"key":"10.3945\/an.112.002758_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ajcn\/83.1.5","article-title":"Is it time to reevaluate methyl balance in humans?","volume":"83","author":"Stead","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.112.002758_bib14","series-title":"Folate in health and disease","first-page":"23","article-title":"Biochemical role of folate in cellular metabolism","author":"Wagner","year":"1995"},{"key":"10.3945\/an.112.002758_bib15","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0021-9258(18)61530-3","article-title":"Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine","volume":"262","author":"Jencks","year":"1987","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0005-2744(67)90140-4","article-title":"Feedback inhibition of methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine","volume":"139","author":"Kutzbach","year":"1967","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/an.112.002758_bib17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0006-291X(85)80006-1","article-title":"Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism","volume":"127","author":"Wagner","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3945\/an.112.002758_bib18","doi-asserted-by":"crossref","first-page":"E1095","DOI":"10.1152\/ajpendo.2001.281.5.E1095","article-title":"Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate","volume":"281","author":"Stead","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3945\/an.112.002758_bib19","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes","volume":"263","author":"Yao","year":"1988","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib20","doi-asserted-by":"crossref","first-page":"28299","DOI":"10.1074\/jbc.M501971200","article-title":"Physiological regulation of phospholipid methylation alters plasma homocysteine in mice","volume":"280","author":"Jacobs","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib21","doi-asserted-by":"crossref","first-page":"42358","DOI":"10.1074\/jbc.M204542200","article-title":"An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins","volume":"277","author":"Noga","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11248-006-0008-1","article-title":"Glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme","volume":"15","author":"Luka","year":"2006","journal-title":"Transgenic Res"},{"key":"10.3945\/an.112.002758_bib23","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1096\/fj.07-8227com","article-title":"Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes","volume":"21","author":"Resseguie","year":"2007","journal-title":"FASEB J"},{"key":"10.3945\/an.112.002758_bib24","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/ATVBAHA.108.166421","article-title":"Murine models of hyperhomocysteinemia and their vascular phenotypes","volume":"28","author":"Dayal","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3945\/an.112.002758_bib25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/ATVBAHA.108.164830","article-title":"The homocysteine paradox","volume":"28","author":"Rodionov","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3945\/an.112.002758_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.3945\/an.112.002758_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","article-title":"Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations","volume":"93","author":"Jacques","year":"1996","journal-title":"Circulation"},{"key":"10.3945\/an.112.002758_bib28","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jn\/128.8.1336","article-title":"Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages","volume":"128","author":"Nelen","year":"1998","journal-title":"J Nutr"},{"key":"10.3945\/an.112.002758_bib29","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2003-09-3078","article-title":"Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice","volume":"103","author":"Devlin","year":"2004","journal-title":"Blood"},{"key":"10.3945\/an.112.002758_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nutres.2010.06.017","article-title":"Dietary intake of S-(\u03b1-carboxybutyl)-dl-homocysteine induces hyperhomocysteinemia in rats","volume":"30","author":"Strakova","year":"2010","journal-title":"Nutr Res"},{"key":"10.3945\/an.112.002758_bib31","doi-asserted-by":"crossref","first-page":"36258","DOI":"10.1074\/jbc.M111.265348","article-title":"Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas","volume":"286","author":"Teng","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-006-0106-5","article-title":"Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview","volume":"29","author":"Castro","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.3945\/an.112.002758_bib33","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.3945\/an.112.002758_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jn\/135.1.5","article-title":"Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia?","volume":"135","author":"Zaina","year":"2005","journal-title":"J Nutr"},{"key":"10.3945\/an.112.002758_bib35","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1161\/01.STR.0000131749.81508.18","article-title":"Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice","volume":"35","author":"Dayal","year":"2004","journal-title":"Stroke"},{"key":"10.3945\/an.112.002758_bib36","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/hh1101.092180","article-title":"Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine \u03b2-synthase-deficient mice","volume":"88","author":"Dayal","year":"2001","journal-title":"Circ Res"},{"key":"10.3945\/an.112.002758_bib37","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood-2006-02-005991","article-title":"Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia","volume":"108","author":"Dayal","year":"2006","journal-title":"Blood"},{"key":"10.3945\/an.112.002758_bib38","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/j.1538-7836.2003.00482.x","article-title":"Effect of mechanical ventilation on carotid artery thrombosis induced by photochemical injury in mice","volume":"1","author":"Wilson","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.3945\/an.112.002758_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mbc.0000195919.71950.f7","article-title":"The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study","volume":"17","author":"Woodward","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.3945\/an.112.002758_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annu Rev Med"},{"key":"10.3945\/an.112.002758_bib41","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/303654","article-title":"Plasma total cysteine and cardiovascular risk burden: action and interaction","volume":"2012","author":"De Chiara","year":"2012","journal-title":"ScientificWorld Journal"},{"key":"10.3945\/an.112.002758_bib42","article-title":"Cardiovascular effects of B-vitamins and\/or N-3 fatty acids: the Su.Fol.Om3 trial","author":"Blacher","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.3945\/an.112.002758_bib43","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3945\/an.112.002758_bib44","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.3945\/an.112.002758_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial","volume":"109","author":"den Heijer","year":"2007","journal-title":"Blood"},{"key":"10.3945\/an.112.002758_bib46","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.3945\/an.112.002758_bib47","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3945\/an.112.002758_bib48","doi-asserted-by":"crossref","first-page":"1563S","DOI":"10.1093\/ajcn\/86.5.1563S","article-title":"Homocysteine, vitamins, and vascular disease prevention","volume":"86","author":"McCully","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.112.002758_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1017\/S0029665108007076","article-title":"Homocysteine, B-vitamins and CVD","volume":"67","author":"McNulty","year":"2008","journal-title":"Proc Nutr Soc"},{"key":"10.3945\/an.112.002758_bib50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/10641963.2010.549274","article-title":"Associations of plasma homocysteine levels with arterial stiffness in prehypertensive individuals","volume":"33","author":"Kim","year":"2011","journal-title":"Clin Exp Hypertens"},{"key":"10.3945\/an.112.002758_bib51","doi-asserted-by":"crossref","first-page":"E1061","DOI":"10.1152\/ajpendo.00367.2010","article-title":"Homocysteine impairs coronary artery endothelial function by inhibiting tetrabiopterin in patients with hyperhomocysteinemia","volume":"299","author":"He","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3945\/an.112.002758_bib52","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/CIRCULATIONAHA.108.808675","article-title":"MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis","volume":"119","author":"Antoniades","year":"2009","journal-title":"Circulation"},{"key":"10.3945\/an.112.002758_bib53","first-page":"474","article-title":"Homocysteine-lowering treatment with folic acid, cobalamin, and pyroidoxine does not suppress blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with prior TIA or stroke","volume":"36","author":"Hankey","year":"2005","journal-title":"Stroke"},{"key":"10.3945\/an.112.002758_bib54","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00109-011-0778-7","article-title":"Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis","volume":"89","author":"Jacobs","year":"2011","journal-title":"J Mol Med"},{"key":"10.3945\/an.112.002758_bib55","doi-asserted-by":"crossref","first-page":"A245","DOI":"10.1136\/jech.2011.142976i.25","article-title":"High levels of plasma homocysteine predicts development of hypertension in a general population: the Tanushimaru study","volume":"65","author":"Fukami","year":"2011","journal-title":"J Epidemiol Community Health"},{"key":"10.3945\/an.112.002758_bib56","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1515\/cclm-2011-0856","article-title":"Plasma total homocysteine is a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension","volume":"50","author":"Bogdanski","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.3945\/an.112.002758_bib57","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2337\/diacare.20.12.1880","article-title":"Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM","volume":"20","author":"Hofmann","year":"1997","journal-title":"Diabetes Care"},{"key":"10.3945\/an.112.002758_bib58","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/meta.2001.25655","article-title":"Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy","volume":"50","author":"Poirier","year":"2001","journal-title":"Metabolism"},{"key":"10.3945\/an.112.002758_bib59","first-page":"494","article-title":"Type 1 diabetes mellitus and homocyst(e)ine","volume":"20","author":"Robillon","year":"1994","journal-title":"Diabete Metab"},{"key":"10.3945\/an.112.002758_bib60","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/diabetes.47.12.1967","article-title":"Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat","volume":"47","author":"Jacobs","year":"1998","journal-title":"Diabetes"},{"key":"10.3945\/an.112.002758_bib61","doi-asserted-by":"crossref","first-page":"43740","DOI":"10.1074\/jbc.M107553200","article-title":"Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver","volume":"276","author":"Jacobs","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib62","doi-asserted-by":"crossref","first-page":"E1235","DOI":"10.1152\/ajpendo.00237.2006","article-title":"Folate status modulates the induction of hepatic glycine N-methyltransferase and homocysteine metabolism in diabetic rats","volume":"291","author":"Nieman","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3945\/an.112.002758_bib63","doi-asserted-by":"crossref","first-page":"45708","DOI":"10.1074\/jbc.M408664200","article-title":"Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid","volume":"279","author":"Nieman","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib64","doi-asserted-by":"crossref","first-page":"42912","DOI":"10.1074\/jbc.M206588200","article-title":"Hormonal regulation of cystathionine \u03b2-synthase expression in liver","volume":"277","author":"Ratnam","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3945\/an.112.002758_bib65","doi-asserted-by":"crossref","first-page":"E933","DOI":"10.1152\/ajpendo.00498.2005","article-title":"Effects of diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat liver","volume":"290","author":"Ratnam","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3945\/an.112.002758_bib66","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.RES.0000129182.46440.4a","article-title":"Modulation of cystathionine \u03b2-synthase level regulates total serum homocysteine in mice","volume":"94","author":"Wang","year":"2004","journal-title":"Circ Res"},{"key":"10.3945\/an.112.002758_bib67","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/jn\/136.12.3005","article-title":"Hepatic phosphatidyl-ethanolamine N-methyltransferase expression is increased in diabetic rats","volume":"136","author":"Hartz","year":"2006","journal-title":"J Nutr"},{"key":"10.3945\/an.112.002758_bib68","doi-asserted-by":"crossref","first-page":"E560","DOI":"10.1152\/ajpendo.00105.2011","article-title":"Insulin abrogates perturbation of methyl group and homocysteine metabolism in diabetic rats","volume":"301","author":"Nieman","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3945\/an.112.002758_bib69","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.2337\/diabetes.54.10.2968","article-title":"Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy","volume":"54","author":"Tessari","year":"2005","journal-title":"Diabetes"},{"key":"10.3945\/an.112.002758_bib70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/dmrr.1281","article-title":"Tissue-specific alterations of methyl group metabolism and DNA hypermethylation in the Zucker (type 2) diabetic fatty (ZDF) rat","volume":"28","author":"Williams","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.3945\/an.112.002758_bib71","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1572-0241.2005.41469.x","article-title":"Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease","volume":"100","author":"Danese","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.3945\/an.112.002758_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-010-0643-y","article-title":"Mesenteric vascular remodeling in hyperhomocysteinemia","volume":"348","author":"Munjal","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.3945\/an.112.002758_bib73","doi-asserted-by":"crossref","first-page":"G281","DOI":"10.1152\/ajpgi.00423.2011","article-title":"Hyperhomocysteinemia decreases intestinal motility leading to constipation","volume":"303","author":"Givvimani","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.3945\/an.112.002758_bib74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1155\/2011\/783721","article-title":"MMP-9, homocysteine and CRP circulating levels are associated with intraluminal thrombus thickness of abdominal aortic aneurysms: new implication of the old biomarkers","volume":"31","author":"Wiernicki","year":"2011","journal-title":"Dis Markers"},{"key":"10.3945\/an.112.002758_bib75","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1111\/j.1572-0241.2000.03367.x","article-title":"Increased levels of homocysteine in patients with Crohn's disease are related to folate levels","volume":"95","author":"Chowers","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.3945\/an.112.002758_bib76","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2036.2011.04864.x","article-title":"Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases","volume":"34","author":"Oussalah","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.3945\/an.112.002758_bib77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-4362.2001.00146.x","article-title":"Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne","volume":"40","author":"Schulpis","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.3945\/an.112.002758_bib78","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ajg.2011.28","article-title":"Isotretinoin use and the risk of inflammatory bowel disease","volume":"106","author":"Thakrar","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.3945\/an.112.002758_bib79","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bone.2008.12.018","article-title":"Cysteine, homocysteine and bone mineral density: a role for body composition?","volume":"44","author":"Elshorbagy","year":"2009","journal-title":"Bone"},{"key":"10.3945\/an.112.002758_bib80","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa032546","article-title":"Homocysteine levels and the risk of osteoporotic fracture","volume":"350","author":"van Meurs","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3945\/an.112.002758_bib81","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bone.2006.03.004","article-title":"Homocysteine enhances apoptosis in human bone marrow stromal cells","volume":"39","author":"Kim","year":"2006","journal-title":"Bone"},{"key":"10.3945\/an.112.002758_bib82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2008.10.051","article-title":"Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone","volume":"44","author":"Herrmann","year":"2009","journal-title":"Bone"},{"key":"10.3945\/an.112.002758_bib83","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bone.2009.10.038","article-title":"Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3\u2013E1 cells","volume":"46","author":"Thaler","year":"2010","journal-title":"Bone"},{"key":"10.3945\/an.112.002758_bib84","first-page":"31","article-title":"Hyperhomocysteinemia reduces bone blood flow","volume":"7","author":"Tyagi","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.3945\/an.112.002758_bib85","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1515\/CCLM.2007.352","article-title":"The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial","volume":"45","author":"Herrmann","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.3945\/an.112.002758_bib86","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4088\/JCP.11m07223","article-title":"Relationship between serum homocysteine levels and depressive symptoms: the Cooper Center Longitudinal Study","volume":"73","author":"Gu","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.112.002758_bib87","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ageing\/afr086","article-title":"Testing homocysteine-induced neurotransmitter deficiency, and depression of mood hypothesis in clinical practice","volume":"40","author":"Gariballa","year":"2011","journal-title":"Age Ageing"},{"key":"10.3945\/an.112.002758_bib88","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3945\/an.112.002758_bib89","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","article-title":"Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations","volume":"61","author":"O'suilleabhain","year":"2004","journal-title":"Arch Neurol"},{"key":"10.3945\/an.112.002758_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.parkreldis.2005.10.002","article-title":"Clinical course in Parkinson's disease with elevated homocysteine","volume":"12","author":"O'suilleabhain","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3945\/an.112.002758_bib91","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mds.22866","article-title":"Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease","volume":"25","author":"Lee","year":"2010","journal-title":"Mov Disord"},{"key":"10.3945\/an.112.002758_bib92","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02938409","article-title":"Nutritional therapies in Parkinson's disease","volume":"9","author":"Evatt","year":"2007","journal-title":"Curr Treat Options Neurol"},{"key":"10.3945\/an.112.002758_bib93","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1479-8301.2011.00356.x","article-title":"Serum homocysteine and physical exercise in patients with Parkinson's disease","volume":"11","author":"Nascimento","year":"2011","journal-title":"Psychogeriatrics"},{"key":"10.3945\/an.112.002758_bib94","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neurobiolaging.2009.02.024","article-title":"Midlife homocysteine and late-life dementia in women: a prospective population study","volume":"32","author":"Zylberstein","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.112.002758_bib95","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gps.2303","article-title":"Homocysteine as a predictor of cognitive decline in Alzheimer's disease","volume":"25","author":"Oulhaj","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3945\/an.112.002758_bib96","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/JGP.0b013e3181dba6f1","article-title":"Plasma homocysteine levels and major depressive disorders in Alzheimer's disease","volume":"18","author":"Chen","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3945\/an.112.002758_bib97","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1096\/fj.10-161828","article-title":"Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease","volume":"24","author":"Zhuo","year":"2010","journal-title":"FASEB J"},{"key":"10.3945\/an.112.002758_bib98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clnu.2010.12.004","article-title":"A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people","volume":"30","author":"Kwok","year":"2011","journal-title":"Clin Nutr"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322010699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322010699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/3\/6\/755\/23735587\/755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:11:27Z","timestamp":1761873087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831322010699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S2161831322010699"],"URL":"https:\/\/doi.org\/10.3945\/an.112.002758","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine Imbalance: a Pathological Metabolic Marker","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/an.112.002758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 American Society for Nutrition","name":"copyright","label":"Copyright"}]}}